Guanfacine Dosing and Administration for ADHD

Dosing Guidelines

The recommended dosing regimen for guanfacine in ADHD treatment is 0.1 mg/kg once daily, with available tablet doses of 1, 2, 3, and 4 mg 1, 2, 3
Guanfacine is available in extended-release tablet form with doses of 1, 2, 3, and 4 mg for ADHD treatment 1, 3
Dosing should be adjusted according to body weight, with a general rule of thumb being 0.1 mg/kg administered once daily 2, 3
Once-daily administration is recommended, with evening dosing often preferred due to the common side effect of somnolence 1, 4

Treatment effects are not usually observed until 2-4 weeks after initiation, unlike stimulants which have a more rapid onset 1
Morning administration is preferred for some non-stimulant ADHD medications, but evening dosing may be better for guanfacine due to its sedative effects 1, 3

In Europe, guanfacine is only approved when stimulants are not suitable, not tolerated, or ineffective 3
Guanfacine has shown improved functional impairment and quality of life outcomes beyond core ADHD symptom control 1

Other adverse effects include irritability, insomnia, nightmares, and potential cardiovascular effects (hypotension/bradycardia) 1, 3

Guanfacine has higher specificity for alpha-2A receptors compared to clonidine, potentially resulting in fewer sedative effects 3, 5
Guanfacine is primarily metabolized via CYP3A4 and excreted predominantly through the kidneys 3

Guanfacine is considered a second-line treatment after stimulants, with sufficient but less strong evidence compared to stimulants (which have an effect size of ~1.0 vs guanfacine's ~0.7) 6
Guanfacine may also be used as adjunctive therapy with stimulant medications when stimulant therapy alone is not fully effective 7

For elementary school-aged children (6-11 years): FDA-approved medications including extended-release guanfacine may be prescribed 8
Guanfacine is not recommended for preschool-aged children (4-5 years) as it has not received sufficient rigorous study in this population 7

Common adverse effects include dry mouth, dizziness, irritability, and abdominal pain 7
Cardiovascular effects require monitoring, including decreased heart rate and blood pressure 7
Obtain personal and family cardiac history before starting 7
Consider ECG if risk factors are present 7
Guanfacine should be tapered off rather than suddenly discontinued to prevent rebound hypertension 7
Monitor vital signs regularly, especially during dose adjustments 7

The American College of Obstetricians and Gynecologists recommends a starting dose of 1 mg once daily for guanfacine extended-release in ADHD treatment, with a titration schedule of increasing by 1 mg per week based on clinical response and tolerability, with a target dose range of 0.05 to 0.12 mg/kg/day or 1 to 7 mg/day 9, 10
The maximum recommended dose is 4 mg daily in most clinical contexts, though doses up to 7 mg daily have been used, according to the American College of Obstetricians and Gynecologists 9, 10

Guanfacine should be used with caution in pregnancy, with alternative agents preferred when possible, as recommended by the American College of Obstetricians and Gynecologists 9, 10
The American College of Obstetricians and Gynecologists notes that there are no published studies of guanfacine use while breastfeeding 9, 10
Guanfacine is approved in Canada for children and adolescents aged 6-17 years only, as stated by the American College of Obstetricians and Gynecologists 9, 10